Products

FOOD SAFETY

 

Screening for Bacterial Contamination on Food Products

QuikAlert

 

SANITATION MONITORING

 

Screening for Bacterial Contamination on Surfaces

MoniTek

 

BACTERIAL CONFIRMATION

 

Fast Confirmation from First Growth Plate

MicroQuik

                                    

MEDICAL PRODUCTS

 

Rapid Point of Care and OTC Tests for Infectious Diseases


VEI’s developments include proprietary chemistry for detecting specific enzymes or proteins of bacteria, which are the cause of specific infectious diseases. VEI’s chemistry is highly accurate and sensitive, easy to use, does not require additional equipment, provides fast results and is stored at room temperature.
 
VEI medical tests provide on the spot results in 10 minutes. A patient sample is obtained on a swab, a VEI reagent is introduced to the swab. After 10 minutes, a second VEI reagent is introduced to the swab. If positive, a color change will be seen on the tip of the swab.


Positive              Negative
   


Other rapid diagnostic tests on the market utilize lateral flow antigen detection. The antigen tests for point of care use require many steps to perform, may require additional equipment, and are only about 65% accurate.

Additional diagnostic systems on the market are NAAT or PCR, which requires expensive laboratory equipment, trained technicians, require complicated steps to perform the test, and days before test results are obtained. NAAT/PCR are known to replicate DNA from dead cells, thus providing false positive results. NAAT/PCR are also compromised by inhibitory factors, which can lead to false negative results. Some NAAT/PCR equipment has been unable to detect mutant strains of Chlamydia, and other bacteria.


VEI’s technology detects a specific enzyme or protein from live viable cells, and will not produce false positive results. There are also no inhibitory factors that will cause false negative results with VEI’s technology. VEI’s technology will also detect mutant strains of Chlamydia.

 

Examples of organisms for which tests have been developed include, Group A Streptococcus, Group B Streptococcus, Chlamydia trachomatis, Candida albicans, Gonorrhea neisseria, Bacterial vaginalis, Gardnerella vaginalis, Staphylococcus aureus, Staphylococcus aureus methicillin resistant, Trichomonas, Chlamydia pneumoniae.

 

 

Development for additional tests is ongoing, and VEI can custom make tests per customer request. 

Some tests are available through BioVei Incorporated.  Please visit their web site at http://www.biovei.com 

 

NEW FLUOROMETRIC DIAGNOSTIC SYSTEM

For Food Safety, Sanitation Monitoring, Water Testing, Medical Diagnostics

FluoroQuik

Detect As Low As 1 CFU

In Under 5 Minutes

No Grow Up Phase Needed In Most Cases

Vista Enterprises Incorporated (VEI) introduces a new fluorometric diagnostic system that can be used to provide a fast diagnosis of low levels of bacteria present in less than 5 minutes for most cases.  This new system incorporates an inexpensive hand held fluorometer which can quickly diagnose a multitude of bacterial infections, diseases and conditions. This diagnostic system was developed by and is unique to VEI.  This system will drastically change the way diagnostic testing is done.  More testing can be done on site rather than sending a specimen to a laboratory.

Tests are being developed for the water, food safety, sanitation, and medical industries.

Please visit http://www.fluorovei.com for more information.